Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders

Proton pump inhibitors (PPIs) are the most widely prescribed medications in the world. According to numerous studies, PPIs have been linked to hyperprolactinemia, which can lead to a variety of sexual and reproductive issues. This review summarizes the effects of numerous PPIs on the blood prolactin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ashfaq Muhammad, Haroon Muhammad Zeeshan, Alkahraman Yasser MSA
Formato: Artigo
Idioma:Inglês
Publicado em: Sciendo 2022-04-01
Colecção:Endocrine Regulations
Assuntos:
proton pump inhibitors
hyperprolactinemia
reproductive symptoms
sexual dys-function
omeprazole
gynecomastia
galactorrhea
erectile dysfunction
Acesso em linha:https://doi.org/10.2478/enr-2022-0015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados